Literature DB >> 30528605

Extracellular matrix derived from chondrocytes promotes rapid expansion of human primary chondrocytes in vitro with reduced dedifferentiation.

Yong Mao1, Travis Block2, Anya Singh-Varma1, Anne Sheldrake2, Rachel Leeth2, Sy Griffey2, Joachim Kohn3.   

Abstract

A significant expansion of autologous chondrocytes in vitro is required for cell-based cartilage repair. However, the in vitro expansion of chondrocytes under standard culture conditions inevitably leads to the dedifferentiation of chondrocytes and contributes to suboptimal clinical outcomes. To address this challenge, we focused our efforts on developing an improved in vitro expansion protocol, which shortens the expansion time with decreased dedifferentiation. It is known that the tissue microenvironment plays a critical role in regulating the cellular functions of resident cells and provides guidance in tissue-specific regeneration. We hypothesized that chondrocyte extracellular matrix (ECM) mimics a native microenvironment and that it may support chondrocyte expansion in vitro. To test this hypothesis, we prepared decellularized ECMs from allogeneic human articular chondrocytes (HAC) (AC-ECM) and bone marrow stromal cells (BM-ECM) and studied their effects on the in vitro expansion of primary HAC. The differential composition and physical properties of these two ECMs were revealed by mass spectrometry and atomic force microscopy. Compared with standard tissue culture polystyrene (TCP) or BM-ECM, HAC cultured on AC-ECM proliferated faster and maintained the highest ratio of COL2A1/COL1A1. Furthermore, a pellet culture study demonstrated that cells expanded on AC-ECM produced a more cartilage-like ECM than cells expanded on BM-ECM or TCP. This is the first report on modulating chondrocyte expansion and dedifferentiation using cell type-specific ECM and on identifying AC-ECM as a preferred substrate for in vitro expansion of HAC cell-based therapies. STATEMENT OF SIGNIFICANCE: To reduce the dedifferentiation of chondrocytes during in vitro expansion, cell type-specific extracellular matrix (ECM), which mimics a native microenvironment, was prepared from human articular chondrocytes (AC-ECM) or bone marrow stromal cells (BM-ECM). As demonstrated by mass spectrometry and atomic force microscopy, AC-ECM and BM-ECM have differential ECM compositions and physical characteristics. Human articular chondrocytes (HAC) expanded faster and maintained a better chondrocyte phenotype on AC-ECM than on BM-ECM or a standard culture surface. AC-ECM has potential to be developed for expanding HAC for cell-based therapies.
Copyright © 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cartilage repair; Dedifferentiation; Extracellular matrix; Human chondrocyte expansion; Matrix compositions; Type II collagen

Mesh:

Substances:

Year:  2018        PMID: 30528605     DOI: 10.1016/j.actbio.2018.12.006

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  13 in total

Review 1.  Dedifferentiation: inspiration for devising engineering strategies for regenerative medicine.

Authors:  Yongchang Yao; Chunming Wang
Journal:  NPJ Regen Med       Date:  2020-07-31

2.  A decellularized flowable placental connective tissue matrix supports cellular functions of human tenocytes in vitro.

Authors:  Yong Mao; Nikita John; Nicole M Protzman; Adam Kuehn; Desiree Long; Raja Sivalenka; Radoslaw A Junka; Anna Gosiewska; Robert J Hariri; Stephen A Brigido
Journal:  J Exp Orthop       Date:  2022-07-18

Review 3.  Biochemical Aspects of Scaffolds for Cartilage Tissue Engineering; from Basic Science to Regenerative Medicine.

Authors:  Davood Yari; Mohammad H Ebrahimzadeh; Jebrail Movaffagh; Azadeh Shahroodi; Moein Shirzad; Durdi Qujeq; Ali Moradi
Journal:  Arch Bone Jt Surg       Date:  2022-03

4.  Preparation of osteogenic matrices from cultured cells.

Authors:  Carl A Gregory; Eoin P McNeill; Simin Pan
Journal:  Methods Cell Biol       Date:  2019-12-10       Impact factor: 1.441

Review 5.  Current Models for Development of Disease-Modifying Osteoarthritis Drugs.

Authors:  Meagan J Makarczyk; Qi Gao; Yuchen He; Zhong Li; Michael S Gold; Mark C Hochberg; Bruce A Bunnell; Rocky S Tuan; Stuart B Goodman; Hang Lin
Journal:  Tissue Eng Part C Methods       Date:  2021-02-04       Impact factor: 3.056

6.  Telmisartan Mitigates TNF-α-Induced Type II Collagen Reduction by Upregulating SOX-9.

Authors:  Xiuying Zhang; Yanfeng Dong; Hanyu Dong; Yanhui Cui; Qing Du; Xiaoli Wang; Lanlan Li; Hongju Zhang
Journal:  ACS Omega       Date:  2021-04-22

Review 7.  Dedifferentiation: inspiration for devising engineering strategies for regenerative medicine.

Authors:  Yongchang Yao; Chunming Wang
Journal:  NPJ Regen Med       Date:  2020-07-31

Review 8.  Autologous costal chondral transplantation and costa-derived chondrocyte implantation: emerging surgical techniques.

Authors:  Youshui Gao; Junjie Gao; Hengyuan Li; Dajiang Du; Dongxu Jin; Minghao Zheng; Changqing Zhang
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-09-23       Impact factor: 5.346

Review 9.  The Role of Fibrosis in Osteoarthritis Progression.

Authors:  Yeri Alice Rim; Ji Hyeon Ju
Journal:  Life (Basel)       Date:  2020-12-23

10.  Imbalanced cellular metabolism compromises cartilage homeostasis and joint function in a mouse model of mucolipidosis type III gamma.

Authors:  Lena Marie Westermann; Lutz Fleischhauer; Jonas Vogel; Zsuzsa Jenei-Lanzl; Nataniel Floriano Ludwig; Lynn Schau; Fabio Morellini; Anke Baranowsky; Timur A Yorgan; Giorgia Di Lorenzo; Michaela Schweizer; Bruna de Souza Pinheiro; Nicole Ruas Guarany; Fernanda Sperb-Ludwig; Fernanda Visioli; Thiago Oliveira Silva; Jamie Soul; Gretl Hendrickx; J Simon Wiegert; Ida V D Schwartz; Hauke Clausen-Schaumann; Frank Zaucke; Thorsten Schinke; Sandra Pohl; Tatyana Danyukova
Journal:  Dis Model Mech       Date:  2020-11-18       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.